评估伴胸痛成人肥厚型心肌病患者冠状动脉粥样硬化的临床意义
本研究纳入238例因胸痛行冠状动脉CT血管成像(CCTA)的成人肥厚型心肌病患者,分析狭窄程度与不良斑块特征。梗阻性冠心病(管腔狭窄≥50%)患病率14.7%,不良斑块特征18.9%;随访中位37个月期间不良心血管事件发生31例(13.0%)。将CCTA变量加入临床和超声心动图因素后,预测不良心血管事件的AUC由0.84、0.88提高至0.92(p<0.001)。
要点
- 伴胸痛成人肥厚型心肌病患者中,CCTA检出梗阻性冠心病(狭窄≥50%)占14.7%,不良斑块特征占18.9%。
- 梗阻性冠心病和不良斑块特征与不良心血管事件相关(多因素Cox回归,均p<0.05)。
- CCTA变量加入临床和超声心动图因素后,不良心血管事件预测AUC由0.84、0.88升至0.92。
核心结论
- 使用CCTA发现约20%的有症状肥厚型心肌病患者合并临床显著的冠状动脉粥样硬化;将CCTA变量加入临床和超声心动图变量可能提高不良心血管事件的预测,因此用CCTA评估冠状动脉粥样硬化可能对有症状的肥厚型心肌病患者有帮助。
研究设计与样本
- 对238例因胸痛行CCTA的成人肥厚型心肌病患者进行纵向随访,分析狭窄程度和不良斑块特征等CCTA变量,并评估结合临床危险因素、超声心动图参数和CCTA变量的三种不良心血管事件预测模型。
诊断标准与关键数值
- 梗阻性冠心病定义为管腔狭窄≥50%,患病率14.7%;不良斑块特征患病率18.9%;随访中位37个月(范围2-108个月),不良心血管事件(全因死亡、心肌梗死、不稳定型心绞痛、心力衰竭、植入式心律转复除颤器植入和卒中)发生31例(13.0%)。
临床应用与阅片要点
- 对伴胸痛的成人肥厚型心肌病患者行CCTA时,应评估管腔狭窄程度(以≥50%为梗阻性标准)和不良斑块特征,这些CCTA变量可能有助于预测不良心血管事件。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Chest pain is a common symptom in patients with hypertrophic cardiomyopathy (HCM), causing difficulty determining whether there is coexistent coronary artery disease (CAD). We investigated whether coronary computed tomography angiography (CCTA) can assess the prevalence and clinical significance of CAD in adult patients with HCM showing chest pain through longitudinal follow-up.
METHODS: In 238 adult patients with HCM, who underwent CCTA for chest pain, we analyzed the degree of stenosis and adverse plaque characteristics (APCs) as CCTA variables. Three prediction models for adverse cardiovascular events (ACEs: all-cause mortality, myocardial infarction, unstable angina, heart failure, implantable cardioverter-defibrillator implantation, and stroke) were assessed using the combination of clinical risk factors, echocardiographic parameters, and CCTA variables.
RESULTS: The prevalence of obstructive CAD (≥ 50% in luminal stenosis) and APC was 14.7% and 18.9%, respectively. During the follow-up period (median, 37 months; range, 2-108 months), there were 31 occurrences of ACEs (13.0%). Using multivariate Cox regression analysis, age, atrial fibrillation, low ejection fraction, obstructive CAD, and APCs were associated with ACEs (all p < 0.05). Among the prediction models for ACEs, the area under the curve (AUC) was higher (AUC = 0.92) when CCTA variables were added to the clinical (AUC = 0.84) and echocardiographic factors (AUC = 0.88) (p < 0.001).
CONCLUSIONS: Using CCTA, about 20% of symptomatic HCM patients were associated with clinically significant atherosclerosis. Adding these CCTA variables to the clinical and echocardiographic variables may increase the predictions of ACEs; therefore, evaluating coronary atherosclerosis using CCTA may be helpful for symptomatic HCM patients.
KEY POINTS: • Chest pain in adult patients with hypertrophic cardiomyopathy (HCM) remains challenging to distinguish from coronary artery disease. • Coronary computed tomography angiography (CCTA) can assess the severity and characteristics of coronary atherosclerosis in symptomatic HCM patients. • Adding CCTA variables to clinical and echocardiographic factors may increase the predictions of adverse cardiac events in HCM patients, and thus evaluating coronary atherosclerosis using CCTA may be helpful for HCM patients with chest pain.
引用
- Shin YJ, Lee JH, Yoo JY, et al. Clinical significance of evaluating coronary atherosclerosis in adult patients with hypertrophic cardiomyopathy who have chest pain. Eur Radiol. 2019. PMID: 30796567. doi:10.1007/s00330-018-5951-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。